Shareholding disclosure
European Investment Bank
Declared position
3.68%
Threshold
Crossed upwards
Timeline
Published
09.09.2021
Transaction
06.09.2021
Voting rights breakdown
Voting rights acquired3.68%
Voting rights sold0%
Below threshold0%
Notice details
CategorySingle shareholder
ExchangeXSWX
Notification ID
TAL9800040
Beneficial owner
European Investment Bank
Declared address
European Investment Bank, Luxembourg
Issuance of additional warrants under an investment agreement and option rights agreement betwen Newron Pharmaceuticals SpA and the European Investment Bank
insider24.ch
Never miss a market signal again
Create a free account
Need more? Discover the Pro plan
Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open